News
Takeda to sell dry eye drug to Novartis for up to $5.3bn
Takeda has announced it is to sell the dry eye drug Xiidra to Novartis, and a surgical patch to Johnson & Johnson, for a potential total of $5.7 billion as it seeks to pay off debts fol
